Inhibition of osteoclast differentiation and bone resorption by sauchinone

Kyoung Youn Han, Daum Yang, Eun Ju Chang, Youngkyun Lee, Hao Huang, Sang Hyun Sung, Zang Hee Lee, Young Choong Kim, Hong Hee Kim*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

55 Scopus citations


Osteoclasts are bone-specific multinucleated cells generated by differentiation of monocyte/macrophage lineage precursors. Regulation of osteoclast differentiation is considered an effective therapeutic approach to the treatment of bone-lytic diseases. In this study, we investigated effects of sauchinone, a lignan from Saururus chinensis, on osteoclastogenesis induced by the differentiation factor RANKL (receptor activator of nuclear factor kappa B ligand). Sauchinone strongly inhibited the osteoclastogenesis from primary bone marrow-derived macrophages (BMMs). This effect was accompanied by a significant decrease in the level of carbonic anhydrase II, calcitonin receptor, MMP9, and TRAP, which are normally upregulated during osteoclast differentiation. For the induction of osteoclastogenesis-associated genes, RANKL activates multiple transcription factors through mechanisms involving mitogen-activated protein kinases (MAPK) and reactive oxygen species (ROS). Sauchinone greatly attenuated the activation of ERK and, less prominently, that of p38 MAPKs by RANKL. The RANKL-stimulated induction of c-Fos and NFATc1 transcription factors was also abrogated by sauchinone. In addition, the activation of AP-1, NFAT, and NF-κB transcription factors was alleviated in sauchinone-treated cells. Sauchinone also diminished the RANKL-stimulated increase of ROS production in BMMs. Consistent with the in vitro anti-osteoclastogenic effect, sauchinone inhibited bone destruction and osteoclast formation caused by lipopolysaccharide in an animal model. Taken together, our data demonstrate that sauchinone inhibits RANKL-induced osteoclastogenesis by reducing ROS generation, which attenuates MAPK and NF-κB activation, ultimately leading to the suppression of c-Fos and NFATc1 induction. Also the in vivo effect of sauchinone on bone erosion strengthens the potential usefulness of this compound for diseases involving bone resorption.

Original languageEnglish (US)
Pages (from-to)911-923
Number of pages13
JournalBiochemical Pharmacology
Issue number6
StatePublished - Sep 15 2007


  • ERK
  • Inhibition of differentiation and bone resorption
  • LPS-induced bone destruction
  • Osteoclast
  • ROS production
  • Sauchinone

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology


Dive into the research topics of 'Inhibition of osteoclast differentiation and bone resorption by sauchinone'. Together they form a unique fingerprint.

Cite this